← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2023Last known activity
Jan 31, 2025
Timeline
2020s
- Apr 25, 2022
Visirna Therapeutics HK Limited— Founded
Drugs by trial phase (5 distinct, 6 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Recent trials (7)
- NCT06766929Lead sponsorPhase 1Jan 31, 2025
- NCT06712771Lead sponsorPhase 3Dec 2, 2024
- NCT06322628Lead sponsorPhase 2Apr 30, 2024
- NCT05902598Study chairPhase 3Jul 1, 2023
- NCT05902598Lead sponsorPhase 3Jul 1, 2023
- NCT05851066Lead sponsorPhase 1Jun 30, 2023
- NCT05757596Lead sponsorPhase 1Jun 1, 2023
Details
- Founded
- Shanghai, CN Apr 25, 2022
- Last known activity
- Jan 31, 2025